600055 Stock Overview
Beijing Wandong Medical Technology Co.,Ltd. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Beijing Wandong Medical Technology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥17.20 |
52 Week High | CN¥18.46 |
52 Week Low | CN¥11.23 |
Beta | -0.059 |
11 Month Change | 20.36% |
3 Month Change | 44.30% |
1 Year Change | -4.07% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -18.44% |
Recent News & Updates
Recent updates
Shareholder Returns
600055 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | 2.6% | -0.9% | -0.6% |
1Y | -4.1% | -10.6% | 3.2% |
Return vs Industry: 600055 exceeded the CN Medical Equipment industry which returned -11.3% over the past year.
Return vs Market: 600055 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
600055 volatility | |
---|---|
600055 Average Weekly Movement | 7.0% |
Medical Equipment Industry Average Movement | 8.6% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600055 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600055's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1955 | 1,059 | Jinsong Song | www.wandong.com.cn |
Beijing Wandong Medical Technology Co.,Ltd. engages in the research, development, manufactures, sales, and after-sale services of digital imaging equipment in China. It operates through two segments Medical Equipment Sales Business; and Medical Services and Others.
Beijing Wandong Medical Technology Co.,Ltd. Fundamentals Summary
600055 fundamental statistics | |
---|---|
Market cap | CN¥12.09b |
Earnings (TTM) | CN¥184.09m |
Revenue (TTM) | CN¥1.40b |
65.7x
P/E Ratio8.6x
P/S RatioIs 600055 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600055 income statement (TTM) | |
---|---|
Revenue | CN¥1.40b |
Cost of Revenue | CN¥849.03m |
Gross Profit | CN¥554.93m |
Other Expenses | CN¥370.85m |
Earnings | CN¥184.09m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.26 |
Gross Margin | 39.53% |
Net Profit Margin | 13.11% |
Debt/Equity Ratio | 0% |
How did 600055 perform over the long term?
See historical performance and comparison